Literature DB >> 17307212

Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).

Bapi Pahar1, Xiaolei Wang, Jason Dufour, Andrew A Lackner, Ronald S Veazey.   

Abstract

CD4(+) T helper and CD8(+) cytotoxic T lymphocyte responses are believed to play an important role in the control of primary HIV and SIV infection. However, the role of these cells in macaques acutely infected with SHIV(sf162p3) has not been well characterized. In this study, ten adult rhesus macaques were intravaginally infected with SHIV(sf162p3), and antigen-specific cytokine responses to SHIV-Tat, Nef, Gag and Env peptide pools were examined through 70 days post inoculation (p.i.) using ELISPOT and/or cytokine flow cytometry (CFC). Peak plasma viral replication occurred between 14 and 21 days p.i. followed by low to undetectable plasma viremia by 70 days of infection in most macaques. Although some animals had strong virus-specific cellular immune responses, many had weak or minimal responses that did not correlate with the post peak decline in plasma viremia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307212      PMCID: PMC1959567          DOI: 10.1016/j.virol.2007.01.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection.

Authors:  R S Veazey; K G Mansfield; I C Tham; A C Carville; D E Shvetz; A E Forand; A A Lackner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Development and homeostasis of T cell memory in rhesus macaque.

Authors:  Christine J Pitcher; Shoko I Hagen; Joshua M Walker; Richard Lum; Bridget L Mitchell; Vernon C Maino; Michael K Axthelm; Louis J Picker
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

3.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Decreased CCR5 expression on CD4+ T cells of SIV-infected sooty mangabeys.

Authors:  Ronald Veazey; Binhua Ling; Ivona Pandrea; Harold McClure; Andrew Lackner; Preston Marx
Journal:  AIDS Res Hum Retroviruses       Date:  2003-03       Impact factor: 2.205

5.  Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).

Authors:  J M Harouse; A Gettie; T Eshetu; R C Tan; R Bohm; J Blanchard; G Baskin; C Cheng-Mayer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 6.  The mucosal immune system: primary target for HIV infection and AIDS.

Authors:  R S Veazey; P A Marx; A A Lackner
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

7.  Differential dynamics of CD4(+) and CD8(+) T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection.

Authors:  A Kaur; C L Hale; S Ramanujan; R K Jain; R P Johnson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus.

Authors:  M A Cromwell; R S Veazey; J D Altman; K G Mansfield; R Glickman; T M Allen; D I Watkins; A A Lackner; R P Johnson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

Authors:  Ronald S Veazey; Robin J Shattock; Melissa Pope; J Christian Kirijan; Jennifer Jones; Qinxue Hu; Tom Ketas; Preston A Marx; Per Johan Klasse; Dennis R Burton; John P Moore
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

10.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  25 in total

1.  Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.

Authors:  Rajeev Gautam; Yoshiaki Nishimura; Wendy R Lee; Olivia Donau; Alicia Buckler-White; Masashi Shingai; Reza Sadjadpour; Stephen D Schmidt; Celia C LaBranche; Brandon F Keele; David Montefiori; John R Mascola; Malcolm A Martin
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

Review 2.  Animal models for microbicide studies.

Authors:  Ronald S Veazey; Robin J Shattock; Per Johan Klasse; John P Moore
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.

Authors:  Tara R Henning; Debra Hanson; Sundaram A Vishwanathan; Katherine Butler; Charles Dobard; Gerardo Garcia-Lerma; Jessica Radzio; James Smith; Janet M McNicholl; Ellen N Kersh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10-14       Impact factor: 2.205

4.  Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.

Authors:  Ellen N Kersh; Wei Luo; Qi Zheng; Debra R Adams; Debra Hanson; Ae S Youngpairoj; Mian-er Cong; Katherine Butler; R Michael Hendry; Janet M McNicholl; Walid Heneine; J Gerardo Garcia-Lerma
Journal:  J Infect Dis       Date:  2012-06-27       Impact factor: 5.226

5.  Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.

Authors:  Christopher Sundling; Sijy O'Dell; Iyadh Douagi; Mattias N Forsell; Andreas Mörner; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  Simian immunodeficiency virus infection in rhesus macaques induces selective tissue specific B cell defects in double positive CD21+CD27+ memory B cells.

Authors:  Arpita Das; Ronald S Veazey; Xiaolei Wang; Andrew A Lackner; Huanbin Xu; Bapi Pahar
Journal:  Clin Immunol       Date:  2011-05-12       Impact factor: 3.969

7.  Lack of T-cell-mediated IL-2 and TNFα production is linked to decreased CD58 expression in intestinal tissue during acute simian immunodeficiency virus infection.

Authors:  Diganta Pan; Arpita Das; Sudesh K Srivastav; Vicki Traina-Dorge; Peter J Didier; Bapi Pahar
Journal:  J Gen Virol       Date:  2018-11-29       Impact factor: 3.891

8.  Control of viremia and maintenance of intestinal CD4(+) memory T cells in SHIV(162P3) infected macaques after pathogenic SIV(MAC251) challenge.

Authors:  Bapi Pahar; Andrew A Lackner; Michael Piatak; Jeffrey D Lifson; Xiaolei Wang; Arpita Das; Binhua Ling; David C Montefiori; Ronald S Veazey
Journal:  Virology       Date:  2009-03-18       Impact factor: 3.616

9.  Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas.

Authors:  Smriti Mehra; Bapi Pahar; Noton K Dutta; Cecily N Conerly; Kathrine Philippi-Falkenstein; Xavier Alvarez; Deepak Kaushal
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge.

Authors:  Elizabeth J Faul; Pyone P Aye; Amy B Papaneri; Bapi Pahar; James P McGettigan; Faith Schiro; Inna Chervoneva; David C Montefiori; Andrew A Lackner; Matthias J Schnell
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.